In situ radiotherapy with 111In-pentetreotide: Initial observations and future directions

Cancer Journal from Scientific American

Volumn 4, Issue 2, 1998, Pages 94-102

  McCarthy, Kevin E ^a   Woltering, Eugene A ^a,b   Espenan, Gregory D ^a   Cronin, Michele ^a   Maloney, Thomas J ^c   Anthony, Lowell B ^a,d  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Iso tex Diagnostics Inc   (United States)

^d Hematology Oncology Specialists   (United States)

Author keywords

111In pentetreotide; Auger electron; Clinical trial; Radiation therapy; Somatostatin; Somatostatin receptor

Indexed keywords

ALPHA2B INTERFERON; CISPLATIN; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; OCTREOTIDE; PACLITAXEL; PENTETREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR; TAMOXIFEN; VINCRISTINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; INDIUM; SOMATOSTATIN;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GASTROINTESTINAL TUMOR; HEMOGLOBINOPATHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PANCREAS TUMOR; PRIORITY JOURNAL; TREATMENT OUTCOME; MIDDLE AGED; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; RADIATION DOSE;

ADULT; AGED; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; INDIUM RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PILOT PROJECTS; RADIOTHERAPY DOSAGE; SOMATOSTATIN; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0032219459     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Krulich L, Dhariwal AP, McCann SM. Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology 1968;83:783-790.
2. Brazeau P, Vale W, Burgus R et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973;179:77-79.
3. Brazeau P. Somatostatin: a peptide with unexpected physiologic activities. Am J Med 1986;71 [suppl 61B]:8-13.
4. Mozell EJ, Woltering EA, O'Dorisio TM. Non-endocrine applications of somatostatin and octreotide acetate: facts and flights of fancy. Disease-a-Month 1991;37:751-848.
5. Woltering EA, O'Dorisio MS, O'Dorisio TM. The role of radiolabeled somatostatin analogues in the management of cancer patients. In: DeVita VT Jr., Hellman S, Rosenberg SA, eds. Principles and Practices of Oncology, Update. Vol. 9. Philadelphia: Lippincott-Raven, 1995.
6. Raynor K, Murphy WA, Coy DH et al. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Molecular Pharmacology 1993;43:838-844.
7. Raynor K, O'Carroll AM, Kong H et al. Characterization of cloned somatostatin receptors SSTR4 and SSTR5. Mol Pharmacol 1993;44:385-392.
8. Patel PC, Barrie R, Hill N et al. Post-receptor signal transduction mechanisms involved in octreotide-induced inhibition of angiogenesis. Surgery 1994;116:1148-1152.
9. Pan MG, Florio T, Srork PJS. G protein activation of a hormone-stimulated phosphatase in human tumor cells. Science 1992;256: 1215-1217.
10. Zink A, Scherubl H, Kliemann D et al. Inhibitory effect of somatostatin on cAMP accumulation and calcitonin secretion in C-cells: involvement of pertussis toxin-sensitive G-proteins. Mol Cell Endocrinol 1992;86:213-219.
11. 2+ channels in the beta cell. J Biol Chem 1991;266:837-843.
12. Prevost G, Foehrle E, Thomas F et al. Growth of human breast cancer cell lines is inhibited by the somatostatin analogue BIM 23014C (somatuline). Endocrinology 1991;129:323-329.
13. Woltering EA, Barrie R, O'Dorisio TM et al. Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane. J Surg Res 1991;50:245-251.
14. Woltering EA, Alperin-Lea RC, Sharma C et al. Somatostatin analogues: angiogenesis inhibitors with novel mechanisms of action. Invest New Drugs 1997;15:77-86.
15. Danesi R, Agen C, Benelli U et al. Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995). Clinical Cancer Research 1997;3:263-272.
16. Danesi R, Del TM. The effects of the somatostatin analogue octreotide on angiogenesis in vitro. Metabolism 1996;45:49-50.
17. Danesi R, Benelli U, Del Bianchi S et al. Octreotide inhibits endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane and in the rat cornea [abstract]. Proceedings of AACR 1993;34:A2109-A2109.
18. Weckbecker G, Tolcsvai L, Stolz B et al. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariecromy on 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. Cancer Res 1995;54:6334-6337.
19. Reubi JC, Horisberger U, Laissue J. High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interactions? Int J Cancer 1994;56:681-688.
20. Reubi JC, Laissue J, Krenning EP et al. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical applications. J Steroid Biochem Mol Biol 1994;43:27-35.
21. Reubi JC, Schaer JC, Laissue JA et al. Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels. Metabolism 1996;45[suppl 1]:39-41.
22. Reubi JC, Landolt AM. High density of somatostatin receptors in pituitary tumors from acromegalic patients. J Clin Endocrinol Metab 1984;59:1148-1151.
23. 3]-octreotide: the Rotterdam experience with more than 1,000 patients. Eur J Nucl Med 1993;20:716-731.
24. Andersson P, Forssell-Aronsson E, Johanson V et al. Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phel-octreotide. J Nucl Med 1996;37:2002-2006.
25. Sahu SK, Kortylewicz ZP, Baranowska-Kortylewicz J et al. Strand breaks after the decay of iodine-125 in proximity to plasmid pBR322 DNA. Radiat Res 1997;147:401-408.
26. Hofland LJ, van KP, Waaijers M et al. Internalization of isotope-coupled somatostatin analogue [review]. Digestion 1996;57[suppl 1]: 2-6.
27. 125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide [see comments]. Endocrinology 1995;136:3698-3706.
28. Morel G. Internalization and nuclear localization of peptide hormones. Biochem Pharmacol 1994;47:63-76.
29. Meyers MO, Woltering EA, Drouant G et al. Multiply radioiodinated somatostatin analogues induce receptor specific cytotoxicity. J Surg Res 1998; in press.
30. 111In-DTPA-D-Phel]-oc-treotide: a case history. Ann N Y Acad Sci 1994;733:496-506.
31. Krenning EP, Kwekkeboom DJ, de Jong M et al. Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analogue octreotide. Semin Oncol 1994;21:6-14.
32. Reubi JC, Horisberger U, Laissue J. High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction? Int J Cancer 1994;56:681-688.
33. Reubi JC. The role of peptides and their receptors as tumor markers [review]. Endocrinol Metab Clin North Am 1993;22:917-939.
34. Krenning EP, Bakker WH, Kooij PPM er al. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med 1992;33:652-658.
35. Fjalling M, Andersson P, Forssell-Aronsson E et al. Systemic radionuclide therapy using indium-111-DTPA-D-Phel-octreotide in midgut carcinoid syndrome. J Nucl Med 1996;37:1519-1521.
36. Barrie R, Woltering EA, Hajarizaheh H et al. Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent. J Surg Res 1993;55:446-450.
37. Conway MD, Sonmez M, Yang D et al. Inhibition of corneal angiogenesis by octreotide acetate (OA) in a rabbit micropocket model [abstract]. Invest Ophthalmol Vis Sci 1996;37[suppl]: S547.
38. van Hagen PM, Markusse HM, Lamberts SWJ et al. Somatostatin receptor imaging: the presence of somatostatin receptors in rheumatoid arthritis. Arthritis Rheum 1994;37:1521-1527.
39. Reubi JC, Waser B, Markusse HM et al. Vascular somatostatin receptors in synovium from patients with rheumatoid arthritis. Eur J of Pharmacol 1994;271:371-378.